« Back to news

£150 million boost for clinical research infrastructure

£150 million boost for clinical research infrastructure

blog image

The government has announced a £150 million investment in the UK's clinical research infrastructure.

The Clinical Research Infrastructure Initiative brings together funding from the government, Arthritis Research UK, British Heart Foundation, the Wellcome Trust and Cancer Research UK. The new funding adds to the £80m funding already pledged to the initiative, bringing the total capital to over £230 million.

The monies will fund advance clinical research in 23 key projects at centres across the country, including research teams at 15 universities.

Many of these will involve partnerships with pharmaceutical and biotechnology companies.

The investment should enhance the UK's clinical research capabilities and will focus particularly on developing groundbreaking technologies and experimental medicines.

Examples from the 23 projects include:

  • Institute of Cancer Research hoping to revolutionise radiation treatment by targeting tumours more accurately
  • A team made up from seven universities to advance the next frontier on molecular biology, single-cell genomics
  • Teams from the University of Leeds and York who are pioneering the SABRE imaging method to increase the signal of an MRI image up to 100,000 times


The work of these and the other projects will help in identifying the causes of conditions and diseases such as cancer and dementia, and should dramatically speed up diagnosis and treatment.

Announcing the new funding, Chancellor George Osborne said: "The funding will go to 23 truly innovative projects from across the UK today that represent the best of British ingenuity and scientific exploration. The government, charities, universities and industry will be working together to advance our knowledge in combatting the biggest medical challenges of our time."

Life Sciences Minister George Freeman said: "We want to make the UK the best place in the world for life sciences. Building on our existing research infrastructure this investment will speed up the innovation of experimental medicine, strengthen partnerships with industry and charities and boost our economic growth in this exciting sector."

Professor Sir John Savill, Chief Executive of the Medical Research Council, said: "The government entrusted £150 million of funding to this initiative. With generous contributions from Arthritis Research UK, the British Heart Foundation and other partners, we have been able to invest over £230 million in a collaboration that will catalyse innovation and advance our knowledge in completely new areas of research."

Further details about the 23 projects is available here


Share this: